• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p-AKT、p-GSK3β和β-连环蛋白在卵巢上皮癌中的表达及意义

[Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary].

作者信息

Wei Xin, Lü Qing-jie, Sun Han-xue, Qi Ya-fei, Wang Jin-ou, Cao Cheng-cheng

机构信息

Department of Pathology, Shengjing Hospital, China Medical University, Shenyang 110004, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2012 Feb;41(2):86-90.

PMID:22455883
Abstract

OBJECTIVE

To investigate the expressions of phosphorylated protein kinase B (p-AKT), phosphorylated glycogen synthase kinase 3β (p-GSK3β) and β-catenin proteins and to evaluate their relationship with the clinical pathological characteristics in epithelial tumors of the ovary.

METHODS

The expression of p-AKT, p-GSK3β, and β-catenin was detected with immunohistochemical staining (EnVision method) in 10 cases of benign epithelial neoplasia, 10 cases of borderline epithelial neoplasia and 70 cases of ovarian carcinoma. The relationship of the expression of p-AKT, p-GSK3β and β-catenin with the clinical pathological features was analyzed.

RESULTS

The positive expression rates of p-AKT, p-GSK3β and β-catenin in epithelial ovarian carcinoma were 67.1% (47/70), 60.0% (42/70) and 71.4% (50/70), respectively. Compared to the results of benign and borderline epithelial neoplasia, the expression of the three proteins in carcinoma of the ovary was significantly different (all P < 0.05).Positive correlation was found between p-AKT and p-GSK3β, p-GSK3β and β-catenin, and p-AKT and β-catenin in epithelial ovarian carcinoma (r = 0.546, 0.581, 0.500, respectively; all P < 0.05). Compared to the results of benign and borderline epithelial neoplasia, the expression of p-AKT protein in epithelial ovarian carcinoma was significantly different (all P < 0.05). The expression of p-AKT was correlated with the differentiation of epithelial ovarian carcinoma (P < 0.05), but no relationship was found between its expression and histological classification and FIGO staging (P > 0.05). The expression of p-GSK3β and β-catenin in epithelial ovarian carcinoma were both higher than that in benign and borderline epithelial neoplasia (P < 0.05), and correlated with tumor differentiation and FIGO staging (P < 0.05), but no relationship were found between their expression with histological classification (P > 0.05).

CONCLUSIONS

Positive correlations are found between p-AKT, p-GSK3β and β-catenin in epithelial ovarian carcinoma. The activation of β-catenin is possibly correlated with inactivation of p-GSK3β that binds to p-AKT.

摘要

目的

研究磷酸化蛋白激酶B(p-AKT)、磷酸化糖原合酶激酶3β(p-GSK3β)及β-连环蛋白的表达情况,并评估其与卵巢上皮性肿瘤临床病理特征的关系。

方法

采用免疫组织化学染色(EnVision法)检测10例卵巢良性上皮性肿瘤、10例卵巢交界性上皮性肿瘤及70例卵巢癌组织中p-AKT、p-GSK3β及β-连环蛋白的表达情况,并分析p-AKT、p-GSK3β及β-连环蛋白表达与临床病理特征的关系。

结果

卵巢上皮性癌中p-AKT、p-GSK3β及β-连环蛋白的阳性表达率分别为67.1%(47/70)、60.0%(42/70)和71.4%(50/70)。与卵巢良性及交界性上皮性肿瘤相比,卵巢癌中这三种蛋白的表达差异有统计学意义(均P<0.05)。卵巢上皮性癌中p-AKT与p-GSK3β、p-GSK3β与β-连环蛋白、p-AKT与β-连环蛋白之间均呈正相关(r值分别为0.546、0.581、0.500,均P<0.05)。与卵巢良性及交界性上皮性肿瘤相比,卵巢上皮性癌中p-AKT蛋白的表达差异有统计学意义(均P<0.05)。p-AKT的表达与卵巢上皮性癌的分化程度相关(P<0.05),但与组织学分类及国际妇产科联盟(FIGO)分期无关(P>0.05)。卵巢上皮性癌中p-GSK3β及β-连环蛋白的表达均高于卵巢良性及交界性上皮性肿瘤(P<0.05),且与肿瘤分化程度及FIGO分期相关(P<0.05),但与组织学分类无关(P>0.05)。

结论

卵巢上皮性癌中p-AKT、p-GSK3β及β-连环蛋白之间呈正相关。β-连环蛋白的激活可能与结合p-AKT的p-GSK3β失活有关。

相似文献

1
[Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary].p-AKT、p-GSK3β和β-连环蛋白在卵巢上皮癌中的表达及意义
Zhonghua Bing Li Xue Za Zhi. 2012 Feb;41(2):86-90.
2
[Expression and promotor methylation of p73 gene in ovarian epithelial tumors].[卵巢上皮性肿瘤中p73基因的表达及启动子甲基化]
Zhonghua Bing Li Xue Za Zhi. 2012 Jan;41(1):33-8.
3
[Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].[Cx43和Skp2在上皮性卵巢肿瘤中的表达及其临床意义]
Ai Zheng. 2005 Jan;24(1):104-9.
4
[Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer].[人角质形成细胞蛋白6(hK6)表达与上皮性卵巢癌临床病理特征及预后的相关性]
Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):520-3.
5
[Expression of folate receptor alpha in ovarian epithelial tumors].[叶酸受体α在卵巢上皮性肿瘤中的表达]
Zhonghua Bing Li Xue Za Zhi. 2010 Nov;39(11):747-51.
6
[Expression and significance of P53, P21WAF1 and CDK1 proteins in epithelial ovarian cancer].P53、P21WAF1和CDK1蛋白在上皮性卵巢癌中的表达及意义
Ai Zheng. 2009 Aug;28(8):882-5. doi: 10.5732/cjc.008.10417.
7
[Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].[卵巢上皮性癌中血管内皮生长因子的血清水平及表达]
Ai Zheng. 2003 Jan;22(1):58-61.
8
[Expression of hSef and FGF-2 in epithelial ovarian tumor].[人源Sef和碱性成纤维细胞生长因子-2在上皮性卵巢肿瘤中的表达]
Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):770-4.
9
[Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].[卵巢癌中血管内皮生长因子/血管内皮生长因子受体的表达及信号转导和转录激活因子的激活]
Zhonghua Zhong Liu Za Zhi. 2005 Jan;27(1):33-7.
10
[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].卵巢交界性肿瘤和癌的临床病理分析及细胞周期蛋白D1和p53的表达
Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32.